These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20430055)
1. Gene-environment interactions in Parkinson's disease and other forms of parkinsonism. Vance JM; Ali S; Bradley WG; Singer C; Di Monte DA Neurotoxicology; 2010 Sep; 31(5):598-602. PubMed ID: 20430055 [TBL] [Abstract][Full Text] [Related]
2. Heredity in Parkinson's disease: new findings. Lev N; Melamed E Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial injury: a hot spot for parkinsonism and Parkinson's disease? Giasson BI Sci Aging Knowledge Environ; 2004 Dec; 2004(48):pe42. PubMed ID: 15576821 [TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: piecing together a genetic jigsaw. Dekker MC; Bonifati V; van Duijn CM Brain; 2003 Aug; 126(Pt 8):1722-33. PubMed ID: 12805097 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways. Soreq L; Ben-Shaul Y; Israel Z; Bergman H; Soreq H Neurobiol Dis; 2012 Mar; 45(3):1018-30. PubMed ID: 22198569 [TBL] [Abstract][Full Text] [Related]
11. Genetic contributions to Parkinson's disease. Huang Y; Cheung L; Rowe D; Halliday G Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population. Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971 [TBL] [Abstract][Full Text] [Related]
16. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. Hatano T; Kubo S; Sato S; Hattori N J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902 [TBL] [Abstract][Full Text] [Related]
18. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Klein C; Schlossmacher MG Neurology; 2007 Nov; 69(22):2093-104. PubMed ID: 17761553 [TBL] [Abstract][Full Text] [Related]
19. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203 [TBL] [Abstract][Full Text] [Related]
20. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]